DR Healthcare España, S.L., owns the industrial and intellectual property rights to MIGRACALM® throughout the world.
A Spanish capital company, its subsiduary DR HEALTHCARE FRANCE, S.R.L. is the laboratory that manufactures MIGRACALM®.
Currently its activity focuses on the treatment of migraine, and its products are patented and registered in more than 140 countries.
Its Research and Development Department concentrates on the study of health products aimed at pain relief.
Scientific rigour and demanding quality management and control contribute to the production of safe and effective innovative health products.
Share this page
MIGRACALM® alleviates migraine pain by putting pressure on the superficial temporal arteries.